Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus
- PMID: 14727222
- DOI: 10.1086/381093
Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus
Abstract
We assessed all episodes of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia at our hospital during a 12-month period (n=53) and compared those due to heterogeneous vancomycin-intermediate S. aureus (hVISA; n = 5, 9.4%) with those due to vancomycin-susceptible MRSA (n=48). Patients with hVISA bacteremia were more likely to have high bacterial load infections (P=.001), vancomycin treatment failure (persistent fever and bacteremia for >7 days after the start of therapy; P<.001), and initially low serum vancomycin levels (P=.006). These clinical markers of hVISA bacteremia may help focus diagnostic efforts and treatment.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical